Dr Jonathan Sive is a Consultant Haematologist and the Clinical Service Lead for Myeloma at University College London Hospital (UCLH). He is highly experienced in the diagnosis and management of blood cancers, particularly in myeloma and other plasma cell disorders such as MGUS, plasmacytomas and POEMS Syndrome. He also has expertise in the investigation of anaemia and other abnormal blood counts.
He is an active member of the UK Myeloma Research Alliance where he is involved in the planning and management of national clinical trials. He is also an executive member of the UK Myeloma Forum where he coordinates myeloma management and guidelines at a national level. He is the chair of the UK national guidelines group for the initial treatment of myeloma.
Dr Sive completed his specialist haematology training at UCLH and carried out a PhD in Molecular Haematology at Cambridge University, for which he was awarded a Cancer Research UK Clinical Fellowship. He remains actively engaged in a variety of clinical research projects and his work has been widely published in peer-reviewed journals and textbooks.
Dr Sive is dedicated to improving outcomes and wellbeing for his patients, and combines professional, expert advice with a caring and sympathetic manner. He is registered as a provider with all major UK insurance companies and is also happy to see uninsured self -pay patients.